AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Study 15951310 — intervention group
Group type: EXPERIMENTAL
Intervention: 4% dimeticone lotion (applied for eight hours or overnight)
Number of subjects: 253
Study 15951310 — intervention group
Group type: COMPARATOR
Intervention: 0.5% phenothrin liquid (applied for 12 hours or overnight)
Number of subjects: 253
Study 15951310 — intervention group
Group type: EXPERIMENTAL
Intervention: 4% dimeticone lotion
Number of subjects: 253
Study 15951310 — intervention group
Group type: COMPARATOR
Intervention: 0.5% phenothrin liquid
Number of subjects: 253
Study 12401583 — intervention group
Group type: EXPERIMENTAL
Intervention: Isovolemic Hemodilution (IVH)
Number of subjects: 30
Study 12401583 — intervention group
Group type: EXPERIMENTAL
Intervention: Hypervolemic Hemodilution (HVH)
Number of subjects: 30
Study 10449124 — intervention group
Group type: EXPERIMENTAL
Intervention: Aldose reductase inhibitor (ARI) zenarestat
Number of subjects: 0
Study 10449124 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0
Study 8714853 — intervention group
Group type: EXPERIMENTAL
Intervention: EMLA cream applied 60 min prior to local anesthesia
Number of subjects: 33
Study 8714853 — intervention group
Group type: COMPARATOR
Intervention: Control group (no EMLA cream)
Number of subjects: 33
Study 2220573 — intervention group
Group type: EXPERIMENTAL
Intervention: In-field ECG (n = 34)
Number of subjects: 71
Study 2220573 — intervention group
Group type: COMPARATOR
Intervention: No ECG (n = 37)
Number of subjects: 71
Study 2220573 — intervention group
Group type: COMPARATOR
Intervention: No ECG (n = 6 concurrent control patients)
Number of subjects: 71
Study 393076 — intervention group
Group type: EXPERIMENTAL
Intervention: Diazepam 5 mg
Number of subjects: 218
Study 393076 — intervention group
Group type: EXPERIMENTAL
Intervention: Diazepam 10 mg
Number of subjects: 218
Study 393076 — intervention group
Group type: EXPERIMENTAL
Intervention: Diazepam 20 mg
Number of subjects: 218
Study 393076 — intervention group
Group type: EXPERIMENTAL
Intervention: Alcohol 0.5 g/kg
Number of subjects: 218
Study 393076 — intervention group
Group type: EXPERIMENTAL
Intervention: Alcohol 0.8 g/kg
Number of subjects: 218
Study 393076 — intervention group
Group type: EXPERIMENTAL
Intervention: Alcohol 1.2 g/kg
Number of subjects: 218
Study 393076 — intervention group
Group type: EXPERIMENTAL
Intervention: Diazepam 2 mg
Number of subjects: 218
Study 393076 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 218
Study 393076 — intervention group
Group type: EXPERIMENTAL
Intervention: Alcohol with diazepam
Number of subjects: 218
Study 31782023 — intervention group
Group type: EXPERIMENTAL
Intervention: PBMT/sMF with 30 J per site
Number of subjects: 10
Study 31782023 — intervention group
Group type: COMPARATOR
Intervention: Sham (0 J)
Number of subjects: 10
Study 30906300 — intervention group
Group type: EXPERIMENTAL
Intervention: DQB1*02:01
Number of subjects: 373
Study 30906300 — intervention group
Group type: EXPERIMENTAL
Intervention: DQB1*02:02
Number of subjects: 373
Study 30906300 — intervention group
Group type: EXPERIMENTAL
Intervention: DRB1*01:01, DRB1*04:05, DRB1*09:01, DRB1*12:02, DRB1*13:02, DRB1*14:01
Number of subjects: 373
Study 30906300 — intervention group
Group type: EXPERIMENTAL
Intervention: DPB1*05:01
Number of subjects: 373
Study 30906300 — intervention group
Group type: EXPERIMENTAL
Intervention: DPB1*04:01, DPB1*09:01
Number of subjects: 373
Study 29727535 — intervention group
Group type: EXPERIMENTAL
Intervention: Pancreatic kininogenase (120 u, tid) and sildenafil (25 mg, qd at bedtime)
Number of subjects: 93
Study 29727535 — intervention group
Group type: COMPARATOR
Intervention: Sildenafil (25 mg, qd at bedtime)
Number of subjects: 93
Study 25458076 — intervention group
Group type: EXPERIMENTAL
Intervention: Senofilcon‐A soft lenses of -6.00 D
Number of subjects: 16
Study 25458076 — intervention group
Group type: EXPERIMENTAL
Intervention: Senofilcon‐A soft lenses of -3.00 D
Number of subjects: 16
Study 25458076 — intervention group
Group type: EXPERIMENTAL
Intervention: Senofilcon‐A soft lenses of +3.00 D
Number of subjects: 16
Study 25458076 — intervention group
Group type: EXPERIMENTAL
Intervention: Senofilcon‐A soft lenses of +6.00 D
Number of subjects: 16
Study 25458076 — intervention group
Group type: COMPARATOR
Intervention: Positive soft lens powers
Number of subjects: 16
Study 25458076 — intervention group
Group type: COMPARATOR
Intervention: Negative soft lens powers
Number of subjects: 16
Study 25458076 — intervention group
Group type: EXPERIMENTAL
Intervention: All soft lens powers
Number of subjects: 16
Study 23335263 — intervention group
Group type: EXPERIMENTAL
Intervention: Nutrition intervention (dietary sodium reduction, lycopene, omega-3 fatty acids)
Number of subjects: 175
Study 23335263 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 175
Study 21087222 — intervention group
Group type: EXPERIMENTAL
Intervention: Individualized nutritional treatment from a dietitian in the hospital and three home visits after discharge
Number of subjects: 259
Study 21087222 — intervention group
Group type: COMPARATOR
Intervention: Control group (combined Group 2 and Group 3)
Number of subjects: 259
Study 21087222 — intervention group
Group type: EXPERIMENTAL
Intervention: Individualized nutritional treatment
Number of subjects: 259
Study 21087222 — intervention group
Group type: COMPARATOR
Intervention: Control group
Number of subjects: 259
Study 19297636 — intervention group
Group type: EXPERIMENTAL
Intervention: Moderate levels of manipulated expert witness confidence
Number of subjects: 0
Study 19297636 — intervention group
Group type: EXPERIMENTAL
Intervention: Juror extroversion
Number of subjects: 0
Study 19297636 — intervention group
Group type: EXPERIMENTAL
Intervention: Expert witness credibility ratings
Number of subjects: 0
Study 17885542 — intervention group
Group type: EXPERIMENTAL
Intervention: Reduced-sodium, high-potassium salt substitute (65% sodium chloride, 25% potassium chloride, 10% magnesium sulphate)
Number of subjects: 608
Study 17885542 — intervention group
Group type: COMPARATOR
Intervention: Normal salt (100% sodium chloride)
Number of subjects: 608
Study 15491311 — intervention group
Group type: EXPERIMENTAL
Intervention: AmF/SnF2 dentifrice and mouthrinse
Number of subjects: 80
Study 15491311 — intervention group
Group type: COMPARATOR
Intervention: NaF-containing dentifrice and mouthrinse
Number of subjects: 80
Study 12050092 — intervention group
Group type: EXPERIMENTAL
Intervention: Biomarker Feedback (BF)
Number of subjects: 557
Study 12050092 — intervention group
Group type: COMPARATOR
Intervention: Enhanced Usual Care
Number of subjects: 557
Study 9697784 — intervention group
Group type: EXPERIMENTAL
Intervention: Thoracic epidural anesthesia using bupivacaine combined with light general anesthesia
Number of subjects: 40
Study 9697784 — intervention group
Group type: COMPARATOR
Intervention: General endotracheal anesthesia with postoperative intravenous morphine patient-controlled analgesia
Number of subjects: 40
Study 7875666 — intervention group
Group type: EXPERIMENTAL
Intervention: High dose cefotaxime (2 g every 6 hours)
Number of subjects: 143
Study 7875666 — intervention group
Group type: COMPARATOR
Intervention: Low dose cefotaxime (2 g every 12 hours)
Number of subjects: 143
Study 2087437 — intervention group
Group type: EXPERIMENTAL
Intervention: 5-Hydroxytryptamine (2 nmol)
Number of subjects: 19
Study 2087437 — intervention group
Group type: EXPERIMENTAL
Intervention: Bradykinin (2 nmol)
Number of subjects: 19
Study 2087437 — intervention group
Group type: EXPERIMENTAL
Intervention: Mixture of 5-Hydroxytryptamine and Bradykinin (1 nmol + 1 nmol)
Number of subjects: 19
Study 2087437 — intervention group
Group type: COMPARATOR
Intervention: Saline (0.2 ml)
Number of subjects: 19
Study 35195 — intervention group
Group type: EXPERIMENTAL
Intervention: Clobazam 15 mg daily
Number of subjects: 40
Study 35195 — intervention group
Group type: EXPERIMENTAL
Intervention: Clobazam 30 mg daily
Number of subjects: 40
Study 35195 — intervention group
Group type: EXPERIMENTAL
Intervention: Diazepam 15 mg daily
Number of subjects: 40
Study 35195 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 40
Study 30380053 — intervention group
Group type: EXPERIMENTAL
Intervention: Tenofovir
Number of subjects: 1287
Study 30380053 — intervention group
Group type: EXPERIMENTAL
Intervention: Abacavir
Number of subjects: 1287
Study 30380053 — intervention group
Group type: COMPARATOR
Intervention: Control group (ART initiators)
Number of subjects: 1287
Study 30380053 — intervention group
Group type: COMPARATOR
Intervention: Control group (established ART patients)
Number of subjects: 1287
Study 30380053 — intervention group
Group type: EXPERIMENTAL
Intervention: Dolutegravir with a cytosine analogue plus tenofovir or abacavir
Number of subjects: 1287
Study 25575616 — intervention group
Group type: EXPERIMENTAL
Intervention: Methylphenidate transdermal delivery system (MTS)
Number of subjects: 0
Study 25575616 — intervention group
Group type: COMPARATOR
Intervention: Placebo transdermal system (PTS)
Number of subjects: 0
Study 26979588 — intervention group
Group type: EXPERIMENTAL
Intervention: Healthy=green, unhealthy=red (HGUR)
Number of subjects: 196
Study 26979588 — intervention group
Group type: EXPERIMENTAL
Intervention: Healthy=red, unhealthy=green (HRUG)
Number of subjects: 196
Study 26979588 — intervention group
Group type: COMPARATOR
Intervention: No colour (control)
Number of subjects: 196
Study 26979588 — intervention group
Group type: EXPERIMENTAL
Intervention: Unhealthy foods with different colouring schemes
Number of subjects: 196
Study 24275085 — intervention group
Group type: EXPERIMENTAL
Intervention: Mindfulness meditation training
Number of subjects: 76
Study 24275085 — intervention group
Group type: COMPARATOR
Intervention: Music training
Number of subjects: 76
Study 24275085 — intervention group
Group type: COMPARATOR
Intervention: No treatment control
Number of subjects: 76
Study 23631266 — intervention group
Group type: EXPERIMENTAL
Intervention: Regular consumption of school lunches
Number of subjects: 380
Study 23631266 — intervention group
Group type: COMPARATOR
Intervention: No consumption of school lunches
Number of subjects: 380
Study 19858915 — intervention group
Group type: EXPERIMENTAL
Intervention: Group culture
Number of subjects: 18361
Study 19858915 — intervention group
Group type: EXPERIMENTAL
Intervention: Hierarchical culture
Number of subjects: 18361
Study 19858915 — intervention group
Group type: COMPARATOR
Intervention: Organizational culture
Number of subjects: 18361
Study 19858915 — intervention group
Group type: EXPERIMENTAL
Intervention: Mix of culture types emphasizing group culture
Number of subjects: 18361
Study 17846102 — intervention group
Group type: EXPERIMENTAL
Intervention: Citalopram
Number of subjects: 103
Study 17846102 — intervention group
Group type: EXPERIMENTAL
Intervention: Risperidone
Number of subjects: 103
Study 15172084 — intervention group
Group type: EXPERIMENTAL
Intervention: Conjugated equine estrogens (CEE) 0.625 mg
Number of subjects: 84
Study 15172084 — intervention group
Group type: EXPERIMENTAL
Intervention: CEE + medroxyprogesterone acetate (CEE/MPA) 5 mg
Number of subjects: 84
Study 15172084 — intervention group
Group type: EXPERIMENTAL
Intervention: Tibolone 2.5 mg
Number of subjects: 84
Study 11800516 — intervention group
Group type: EXPERIMENTAL
Intervention: Growth hormone treatment
Number of subjects: 0
Study 11800516 — intervention group
Group type: EXPERIMENTAL
Intervention: Insulin-like growth factor-I treatment
Number of subjects: 0
Study 11800516 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0
Study 9591509 — intervention group
Group type: EXPERIMENTAL
Intervention: Estradiol
Number of subjects: 40
Study 9591509 — intervention group
Group type: EXPERIMENTAL
Intervention: Progesterone
Number of subjects: 40
Study 9591509 — intervention group
Group type: EXPERIMENTAL
Intervention: Combination of estradiol and progesterone
Number of subjects: 40
Study 9591509 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 40
Study 7882660 — intervention group
Group type: EXPERIMENTAL
Intervention: Continuing education intervention 'Periodontics in General Practice' including a 1-day seminar, bi-monthly newsletters, individualized 3-monthly comparative feedback, and technical assistance.
Number of subjects: 36
Study 7882660 — intervention group
Group type: EXPERIMENTAL
Intervention: Continuing education intervention 'Periodontics in General Practice' for practices employing hygienists.
Number of subjects: 36
Study 7882660 — intervention group
Group type: COMPARATOR
Intervention: Control group (no intervention).
Number of subjects: 36
Study 3255811 — intervention group
Group type: EXPERIMENTAL
Intervention: Combination therapy (liquid nitrogen + wart paint)
Number of subjects: 3
Study 3255811 — intervention group
Group type: COMPARATOR
Intervention: Liquid nitrogen applied weekly
Number of subjects: 3
Study 3255811 — intervention group
Group type: COMPARATOR
Intervention: Daily application of wart paint (lactic acid one part, salicylic acid one part, collodion four parts)
Number of subjects: 3
Study 29525239 — intervention group
Group type: EXPERIMENTAL
Intervention: Atezolizumab 1200 mg every 3 weeks
Number of subjects: 64
Study 29525239 — intervention group
Group type: COMPARATOR
Intervention: Docetaxel 75 mg/m2 every 3 weeks
Number of subjects: 64
Study 26640973 — intervention group
Group type: EXPERIMENTAL
Intervention: Standardized patient (SP)‐based intervention with feedback on patient-centered techniques
Number of subjects: 61
Study 26640973 — intervention group
Group type: EXPERIMENTAL
Intervention: Standardized patient (SP)‐based intervention
Number of subjects: 61
Study 26640973 — intervention group
Group type: COMPARATOR
Intervention: Control group (SP visits without feedback)
Number of subjects: 61
Study 23666379 — intervention group
Group type: EXPERIMENTAL
Intervention: Focused Shockwave Therapy (FSWT)
Number of subjects: 43
Study 23666379 — intervention group
Group type: COMPARATOR
Intervention: Radial Shockwave Therapy (RSWT)
Number of subjects: 43
Study 23536950 — intervention group
Group type: EXPERIMENTAL
Intervention: Succinate-containing dialysis solution (SCDS)
Number of subjects: 90
Study 23536950 — intervention group
Group type: COMPARATOR
Intervention: Standard bicarbonate dialysis solution
Number of subjects: 90
Study 20510838 — intervention group
Group type: EXPERIMENTAL
Intervention: Programmed distraction during venipuncture (looking at two similar pictures and identifying differences)
Number of subjects: 42
Study 20510838 — intervention group
Group type: COMPARATOR
Intervention: No intervention (pretest sessions)
Number of subjects: 42
Study 19453400 — intervention group
Group type: EXPERIMENTAL
Intervention: Inactivated, aluminium‐adjuvanted, whole‐virion prototype pandemic influenza A (H5N1) vaccine (PanFlu)
Number of subjects: 0
Study 19453400 — intervention group
Group type: EXPERIMENTAL
Intervention: Plasma from a vaccinated individual
Number of subjects: 0
Study 17211365 — intervention group
Group type: EXPERIMENTAL
Intervention: Platelet-rich plasma (PRP) and suture in group A
Number of subjects: 208
Study 17211365 — intervention group
Group type: EXPERIMENTAL
Intervention: PRP, haemostatic sponges and suture in group B
Number of subjects: 208
Study 17211365 — intervention group
Group type: EXPERIMENTAL
Intervention: Haemostatic sponges, suture and compression with gauzes soaked in tranexamic acid in group C
Number of subjects: 208
Study 17211365 — intervention group
Group type: COMPARATOR
Intervention: Dicumarol therapy suspended and replaced by heparin-calcium in group D (control group)
Number of subjects: 208
Study 12950426 — intervention group
Group type: EXPERIMENTAL
Intervention: Lumiracoxib 200 mg twice daily for 8 days
Number of subjects: 65
Study 12950426 — intervention group
Group type: COMPARATOR
Intervention: Placebo for 8 days
Number of subjects: 65
Study 12950426 — intervention group
Group type: EXPERIMENTAL
Intervention: Naproxen 500 mg twice daily for 8 days
Number of subjects: 65
Study 10984372 — intervention group
Group type: EXPERIMENTAL
Intervention: Basophil surface IgE density and FcepsilonRIalpha expression
Number of subjects: 31
Study 10984372 — intervention group
Group type: EXPERIMENTAL
Intervention: Monocyte FcepsilonRIalpha expression
Number of subjects: 31
Study 10984372 — intervention group
Group type: EXPERIMENTAL
Intervention: Eosinophil FcepsilonRIalpha expression
Number of subjects: 31
Study 10984372 — intervention group
Group type: EXPERIMENTAL
Intervention: CD23 expression on basophils and eosinophils
Number of subjects: 31
Study 10984372 — intervention group
Group type: EXPERIMENTAL
Intervention: CD23 expression on monocytes
Number of subjects: 31
Study 8997579 — intervention group
Group type: EXPERIMENTAL
Intervention: S-shaped haptics lenses (trans-sclerally fixed by two sutures)
Number of subjects: 20
Study 8997579 — intervention group
Group type: EXPERIMENTAL
Intervention: Sutureless sulcus self-fixation PCL
Number of subjects: 20
Study 8997579 — intervention group
Group type: COMPARATOR
Intervention: C-loop posterior chamber lenses (control group)
Number of subjects: 20
Study 8365011 — intervention group
Group type: EXPERIMENTAL
Intervention: Laser cautery of the inferior turbinates
Number of subjects: 0
Study 8365011 — intervention group
Group type: COMPARATOR
Intervention: Sub‐mucosal diathermy of the inferior turbinates
Number of subjects: 0
Study 3533755 — intervention group
Group type: EXPERIMENTAL
Intervention: Cefuroxime axetil ester (1.5 g) with probenecid (1.0 g)
Number of subjects: 500
Study 3533755 — intervention group
Group type: COMPARATOR
Intervention: Amoxycillin (3.0 g) plus clavulanic acid (0.25 g) with probenecid (1.0 g)
Number of subjects: 500
Study 30531700 — intervention group
Group type: EXPERIMENTAL
Intervention: 6 sets of squats
Number of subjects: 28
Study 30531700 — intervention group
Group type: EXPERIMENTAL
Intervention: 3 sets of squats
Number of subjects: 28
Study 30531700 — intervention group
Group type: EXPERIMENTAL
Intervention: 12 sets of squats
Number of subjects: 28
Study 27513157 — intervention group
Group type: COMPARATOR
Intervention: Intra-abdominal drainage
Number of subjects: 395
Study 27513157 — intervention group
Group type: EXPERIMENTAL
Intervention: No drainage
Number of subjects: 395
Study 25256866 — intervention group
Group type: EXPERIMENTAL
Intervention: Diurnal sleep (2 hours)
Number of subjects: 24
Study 25256866 — intervention group
Group type: COMPARATOR
Intervention: Wakefulness (no sleep)
Number of subjects: 24
Study 23200600 — intervention group
Group type: EXPERIMENTAL
Intervention: FIL (Flexion in Lying)
Number of subjects: 25
Study 23200600 — intervention group
Group type: COMPARATOR
Intervention: EIL (Extension in Lying)
Number of subjects: 25
Study 21664653 — intervention group
Group type: EXPERIMENTAL
Intervention: Percutaneous nephrolithotomy (PNL)
Number of subjects: 0
Study 21664653 — intervention group
Group type: COMPARATOR
Intervention: Extracorporeal shock wave lithotripsy (ESWL)
Number of subjects: 0
Study 21664653 — intervention group
Group type: EXPERIMENTAL
Intervention: PNL
Number of subjects: 0
Study 21664653 — intervention group
Group type: COMPARATOR
Intervention: ESWL
Number of subjects: 0
Study 18054443 — intervention group
Group type: EXPERIMENTAL
Intervention: Stepped Care (SC): a computerized intervention plus up to three 40-min telephone-based interventions depending on the success of the previous intervention.
Number of subjects: 10803
Study 18054443 — intervention group
Group type: EXPERIMENTAL
Intervention: Full-Care (FC): a computerized intervention plus a fixed number of four 30-min telephone-based interventions.
Number of subjects: 10803
Study 18054443 — intervention group
Group type: COMPARATOR
Intervention: Control Group (CG): untreated group.
Number of subjects: 10803
Study 17319482 — intervention group
Group type: EXPERIMENTAL
Intervention: Single-dose extended-release epidural morphine (EREM) 10, 20, or 30 mg
Number of subjects: 120
Study 12714115 — intervention group
Group type: EXPERIMENTAL
Intervention: Aspirin (low dose of 100mg daily or less)
Number of subjects: 1007
Study 12714115 — intervention group
Group type: EXPERIMENTAL
Intervention: NSAIDs without aspirin
Number of subjects: 1007
Study 12714115 — intervention group
Group type: EXPERIMENTAL
Intervention: Aspirin (for individuals aged 75 years and over)
Number of subjects: 1007
Study 12714115 — intervention group
Group type: EXPERIMENTAL
Intervention: Aspirin (for individuals younger than 75 years)
Number of subjects: 1007
Study 12714115 — intervention group
Group type: EXPERIMENTAL
Intervention: NSAIDs
Number of subjects: 1007
Study 10745145 — intervention group
Group type: EXPERIMENTAL
Intervention: Anxiety reduction protocol including a booklet, tape-recorded demonstration, control room visit, music volume adjustment device, precise scan timings, and visible clock during scanning.
Number of subjects: 64
Study 10745145 — intervention group
Group type: COMPARATOR
Intervention: Standard procedures with limited information given in advance.
Number of subjects: 64
Study 10745145 — intervention group
Group type: EXPERIMENTAL
Intervention: Experimental group with anxiety reduction protocol.
Number of subjects: 64
Study 9374129 — intervention group
Group type: EXPERIMENTAL
Intervention: Atorvastatin 80 mg daily
Number of subjects: 7
Study 9374129 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 7
Study 1539812 — intervention group
Group type: EXPERIMENTAL
Intervention: Epidural fentanyl administration
Number of subjects: 16
Study 1539812 — intervention group
Group type: COMPARATOR
Intervention: Intravenous fentanyl administration
Number of subjects: 16
Study 1539812 — intervention group
Group type: EXPERIMENTAL
Intervention: Both epidural and intravenous fentanyl
Number of subjects: 16
Study 3993611 — intervention group
Group type: EXPERIMENTAL
Intervention: USDA Women, Infants and Children (WIC) Food Supplementation vouchers
Number of subjects: 410
Study 3993611 — intervention group
Group type: EXPERIMENTAL
Intervention: USDA Women, Infants and Children (WIC) Food Supplementation vouchers (in smokers)
Number of subjects: 410
Study 3993611 — intervention group
Group type: COMPARATOR
Intervention: No supplementation (Control)
Number of subjects: 410
Study 30396739 — intervention group
Group type: EXPERIMENTAL
Intervention: Budesonide inhalation preoperatively
Number of subjects: 60
Study 30396739 — intervention group
Group type: COMPARATOR
Intervention: Saline treatment
Number of subjects: 60
Study 28575379 — intervention group
Group type: EXPERIMENTAL
Intervention: Zinc supplementation (n=121)
Number of subjects: 212
Study 28575379 — intervention group
Group type: COMPARATOR
Intervention: Placebo (n=91)
Number of subjects: 212
Study 28575379 — intervention group
Group type: EXPERIMENTAL
Intervention: Zinc supplementation
Number of subjects: 212
Study 26853645 — intervention group
Group type: EXPERIMENTAL
Intervention: Catheter-directed thrombolysis
Number of subjects: 176
Study 26853645 — intervention group
Group type: COMPARATOR
Intervention: Control group (standard treatment with compression stockings and anticoagulants)
Number of subjects: 176
Study 26853645 — intervention group
Group type: COMPARATOR
Intervention: Control group (standard treatment)
Number of subjects: 176
Study 26853645 — intervention group
Group type: COMPARATOR
Intervention: Catheter-directed thrombolysis and Control group
Number of subjects: 176
Study 23446197 — intervention group
Group type: EXPERIMENTAL
Intervention: Paliperidone palmitate (PP; 234 mg day 1 and 156 mg day 8)
Number of subjects: 292